Samsung Biologics, which has enjoyed a booming contract drug manufacturing streak over the past year, has inked another ...

Post-COVID boardroom shifts and policy tailwinds are catalysing a once-in-a-generation opportunity, Khemani says ...

Laurus Labs stock was quoting at ₹618.50, down 4.18 per cent from the previous session's closing price of ₹645.50 ...

The stock fell 3.22 per cent to Rs 626.25 on BSE. Jefferies maintained its 'Underperform' on Laurus with a target of Rs 480, ...

/news/home/20250424617540/en/PCI-Pharma-Services-to-Acquire-US-based-Aseptic-Fill-Finish-CDMO-Ajinomoto-Althea ...

Jefferies lowered the firm’s price target on Agilent (A) to $116 from $135 and keeps a Hold rating on the shares after having hosted a call ...

Laurus Labs' net profit during the March quarter was aided by a 3x jump in its other income, which grew to ₹58.6 crore from ...

Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate in the ...